[1]
R. K. Sayyid, “What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?”, CUAJ, vol. 11, no. 3-4, pp. 118–22, Apr. 2017.